Two LDS Church historians discuss the diaries of William Clayton, faith founder Joseph Smith's scribe, and what the reveals ...
Reader, it’s a note-taking tool too. While the recent Colorsoft range of Kindles with colour screens featured a base model, a ...
Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly ...
1dOpinion
AI in medicine: model makers need a Marketing 101 lesson—focus on what customer need must be met
Artificial intelligence promises much in the field of healthcare. But too much of what’s on offer is not oriented to the ...
The Pioneer on MSN
Can AI give doctors back the one thing they are running out of - time?
India, July 21 -- Spend an evening in almost any busy clinic and you notice something that rarely makes the news. Long after ...
Why this 2-year-old San Francisco company filed for an IPO © 2026 American City Business Journals. All rights reserved. Use ...
Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...
New Zealand-based rugby writer Liam Napier says the All Blacks will emerge stronger and more united from the Rugby's Greatest ...
Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, is seeking to raise as much as $107.2 million in a US initial public offering.
Scribe Therapeutics on Monday said it plans to sell 7.15 million shares at between $13 and $15 apiece in its initial public offering. At the $14 midpoint of that price range, the Alameda, Calif., ...
Best Buy US is having a late Prime Day sale until Sunday, July 26th. Score a Kindle, Paperwhite, Paperwhite Signature Edition ...
Minister hails Omoniyi Ibietan's re-election as APRA Secretary-General, recognizing his professionalism and contributions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results